The Translational Psychedelics Research Program brings together scientists and providers to understand how psychedelics impact the brain and other organ systems
@TrPR_Program is recruiting research scholars to help investigate the therapeutic mechanisms and efficacy of psychedelic treatments for multiple disorders. Diverse backgrounds and perspectives welcome! psychedelics.ucsf.edu/blog/r…@UCSFPsychiatry
Great read @thebandlab! It is a remarkable time for the future of psychedelic medicines and we are proud to be part of the developments alongside a remarkable team.
We @TrPR_Program@ucsf agree that this is an exciting time for psychedelic research in the Bay! Here’s a link to the ucsf magazine article that describes our efforts @ucsf
As we are talking about psychedelic research at @ucsf and @StanfordMed, would like to highlight our ongoing collaboration w/ @TheBorisLab on a trial of psilocybin for chronic low back pain starting recruitment shortly.
I had a great time interviewing Dr. David Gard about psilocybin-assisted therapy, and how psychologists may be integrating such tools into future practice. He also shared some updates about the @TrPR_Program trial of 🍄 for depression in #bipolardisorder type 2. More 📽️ to come!
NEW EPISODE! #talkBD🍄
Researcher/psychologist Dr. David Gard breaks down the latest research on psychedelics in supporting mental health, use of psilocybin to treat #bipolar, and reviews the benefits and risks.
📺Stream on YouTube/all podcast platforms: talkBD.live/psilocybin
Nice to see @TrPR_Program work referenced in the NYT nytimes.com/2023/02/10/well/… risk of psychedelics causing mania/psychosis especially in people with personal or fam hx of bipolar is complex. If it occurs, the rates must be very low. We are conducting a trial in bd2 to learn more.
Are you or someone you know currently depressed and have bipolar 2 disorder? @Trpr_program is recruiting for a trial of psilocybin therapy. To learn more, for to psychedelics.ucsf.edu or email psilocybinstudies@ucsf.edu.
An international web-based survey on experiences of psilocybin consumption found that 32.2% of respondents w/ bipolar disorder described new/increasing symptoms after psilocybin trips.
ucsfpsy.ch/40tG5gu
Excited to announce a new milestone for TrPR. This week we successfully dosed three participants with psilocybin. Our capacity to deliver psychedelic therapy is increasing.
Could psychedelics become mainstream medicines? “Trip Therapy,” my cover story for UCSF Magazine is out now, featuring gorgeous illustrations by
@marcoschinart: magazine.ucsf.edu/psychedeli…
It’s such a delight to see this on the cover. Many thanks to the researchers at @TrPR_Program and @neuroscapeucsf (and many others) who spoke to me for this article! And, of course, thanks to my excellent editor @BleicherAriel.
The longer people with #anorexia go untreated, “the worse the chance of recovery is," UCSF's Dr. Amanda Downey (@drdowneydoes) says. Downey & team will be studying the impact of psychedelics on younger patients with the #EatingDisorder. ucsfh.org/3VT4l8h
The longer people with #anorexia go untreated, “the worse the chance of recovery is," UCSF's Dr. Amanda Downey (@drdowneydoes) says. Downey & team will be studying the impact of psychedelics on younger patients with the #EatingDisorder. ucsfh.org/3VT4l8h
TrPR is currently recruiting Cantonese/Mandarin speaking research assistants and facilitators! The primary function of this position is to provide psychotherapy services for the Translational Psychedelic Research Program.
The clinical social worker will provide evidence-based psychotherapy under the research protocol. Under the supervision of senior clinical staff, they will provide psychotherapy, using evidence-based practices. They will also provide crisis intervention and emotional support.